Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Biological Chemistry

Opioid Receptor Gang Of Four

Scientists obtain structures of the d-opioid and nociception receptors, rounding out analyses of the four opioid receptor subtypes

by Stu Borman
May 21, 2012 | A version of this story appeared in Volume 90, Issue 21

Credit: Nature
Credit: Nature
\
\

 

\
Credit: Nature
Credit: Nature
\
\

 

\

At top, a space-filling structure of the δ-opioid receptor bound to an antagonist (center), and at bottom a ribbon structure of the nociceptin receptor bound to an antagonist (spheres). Disks represent membrane surfaces.

Researchers have completed crystal structure analyses of the last of the four types of opioid receptors. These receptors are targets for antidepressants and pain and reward agents such as morphine. The structures were previously unavailable because opioid receptors, which are membrane proteins, would not form crystals. They were obtained through a technique that conjugates an opioid receptor to a crystallizable protein. This strategy led to antagonist-bound structures reported in March for the µ-opioid receptor by Brian K. Kobilka and Sébastien Granier of Stanford University and coworkers and the κ-opioid receptor by a group led by Raymond C. Stevens of Scripps Research Institute (C&EN, March 26, page 11). Now, the Stanford group has solved the δ-opioid receptor structure, and the Scripps team has reported the nociceptin (orphanin FQ) receptor structure, both bound to antagonists, rounding out the gang of four opioid receptor subtypes (Nature, DOI: 10.1038/nature11111 and 10.1038/nature11085). The crystal structures help elucidate how drugs bind the opioid receptors and could lead to optimization of the growing list of opioid therapeutics.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.